<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chan ACY</submitter><funding>Ministry of Education - Singapore</funding><funding>National Medical Research Council</funding><pagination>219</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12486793</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>Small fiber neuropathy (SFN) affects small-diameter sensory and autonomic nerve fibers, leading to chronic pain and autonomic dysfunction. While SFN can be associated with diabetes and autoimmune diseases, a significant proportion of cases are idiopathic. Although immune-mediated mechanisms are being recognized increasingly in SFN, their precise role remains unclear. This study investigates the presence of autoantibodies against interferon-induced GTP-binding protein MX (MX1) in SFN patients and explores their potential pathogenic role. A total of 59 patients with skin biopsy-confirmed SFN and 20 healthy controls were recruited. Serum samples were analyzed for the presence of anti-MX1 autoantibodies using enzyme-linked immunosorbent assay (ELISA). Immunohistochemistry was performed on rat </pubmed_abstract><journal>Journal of neuroinflammation</journal><pubmed_title>Interferon-induced GTP-binding protein MX1 drives hyperexcitability in peripheral nerves: a novel mechanism in small fiber neuropathy.</pubmed_title><pmcid>PMC12486793</pmcid><funding_grant_id>NUHSRO/2021/059/T1/Seed-Mar/02</funding_grant_id><funding_grant_id>MOH-000437-00</funding_grant_id><pubmed_authors>Sharma VK</pubmed_authors><pubmed_authors>Wong HY</pubmed_authors><pubmed_authors>Huang H</pubmed_authors><pubmed_authors>Teoh HL</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Soong TW</pubmed_authors><pubmed_authors>Foo NWJ</pubmed_authors><pubmed_authors>Mak A</pubmed_authors><pubmed_authors>Chan ACY</pubmed_authors><pubmed_authors>Shah A</pubmed_authors><pubmed_authors>Mohammad Rizal NAB</pubmed_authors><pubmed_authors>Schwarz H</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interferon-induced GTP-binding protein MX1 drives hyperexcitability in peripheral nerves: a novel mechanism in small fiber neuropathy.</name><description>Small fiber neuropathy (SFN) affects small-diameter sensory and autonomic nerve fibers, leading to chronic pain and autonomic dysfunction. While SFN can be associated with diabetes and autoimmune diseases, a significant proportion of cases are idiopathic. Although immune-mediated mechanisms are being recognized increasingly in SFN, their precise role remains unclear. This study investigates the presence of autoantibodies against interferon-induced GTP-binding protein MX (MX1) in SFN patients and explores their potential pathogenic role. A total of 59 patients with skin biopsy-confirmed SFN and 20 healthy controls were recruited. Serum samples were analyzed for the presence of anti-MX1 autoantibodies using enzyme-linked immunosorbent assay (ELISA). Immunohistochemistry was performed on rat </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T08:45:52.387Z</modification><creation>2026-05-14T03:12:28.931Z</creation></dates><accession>S-EPMC12486793</accession><cross_references><pubmed>41035025</pubmed><doi>10.1186/s12974-025-03557-6</doi></cross_references></HashMap>